U.S. markets close in 2 hours 34 minutes

Trump Touts Drug, FDA Says Not Yet Approved

Mar.20 -- At a press conference at the White House Thursday, President Donald Trump and the head of the Food and Drug Administration, Stephen Hahn, gave apparently conflicting comments about the availability of chloroquine, a malaria drug, to treat Covid-19 patients. John Lauerman reports on "Bloomberg Markets: European Open."